awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36281063-E8A50046-984D-4897-903B-15CE48A52ED7
Q36281063-E8A50046-984D-4897-903B-15CE48A52ED7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36281063-E8A50046-984D-4897-903B-15CE48A52ED7
Optimal duration of allergic rhinitis clinical trials.
P2860
Q36281063-E8A50046-984D-4897-903B-15CE48A52ED7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36281063-E8A50046-984D-4897-903B-15CE48A52ED7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9220a572ce4722b2866243d30e88958add9f2d95
P2860
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis.